Abacus Medicine A/S (DB:ABC) agreed to acquire Pluripharm Groep B.V. on July 13, 2020. Pluripharm will continue to operate under its current name. Pluripharm achieved revenue of €248 million in 2019. Effective immediately, Léon Tinke, previously Director of Pharmacy with Pluripharm, has been promoted to Chief Executive Officer. The acquisition is contingent upon consultation with relevant labour unions and the expected approval of the competition authorities in Germany and the Netherlands.